Drug Side Effects
Search
FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
was reported 31 times
FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interferon gamma Blocker [EPC]
1
0.0042
1
CD52-directed Cytolytic Antibody [EPC]
6
0.0003
2
Interleukin-1 Receptor Antagonist [EPC]
3
0.0002
3
Calcineurin Inhibitor Immunosuppressant [EPC]
10
0.0001
4
Topoisomerase Inhibitor [EPC]
5
0.0001
5
Antimetabolite Immunosuppressant [EPC]
1
0.0000
6
Provitamin D2 Compound [EPC]
1
0.0000
7
Janus Kinase Inhibitor [EPC]
5
0.0000
8
Leukocyte Growth Factor [EPC]
4
0.0000
9
Alkylating Drug [EPC]
6
0.0000
10
Folate Analog Metabolic Inhibitor [EPC]
9
0.0000
11
Interleukin-6 Receptor Antagonist [EPC]
2
0.0000
12
Integrin Receptor Antagonist [EPC]
1
0.0000
13
Acetylcholine Release Inhibitor [EPC]
1
0.0000
14
Kinase Inhibitor [EPC]
5
0.0000
15
Corticosteroid [EPC]
11
0.0000
16
Prostacycline Vasodilator [EPC]
1
0.0000
17
Endothelin Receptor Antagonist [EPC]
1
0.0000
18
Opioid Agonist [EPC]
1
0.0000
19
Platinum-based Drug [EPC]
1
0.0000
20
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
21
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
22
Proton Pump Inhibitor [EPC]
1
0.0000